{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:48:43Z","timestamp":1792633723944,"version":"4.5.0"},"reference-count":56,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2021,12,1]]},"DOI":"10.1001\/jamainternmed.2021.5714","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T21:50:38Z","timestamp":1633384238000},"page":"1562","source":"Crossref","is-referenced-by-count":142,"title":["Association of Statin Therapy Initiation With Diabetes Progression"],"prefix":"10.1001","volume":"181","author":[{"given":"Ishak A.","family":"Mansi","sequence":"first","affiliation":[{"name":"Department of Medicine, VA North Texas Health Care System, Dallas"},{"name":"Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas"},{"name":"Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Chansard","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildiko","family":"Lingvay","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas"},{"name":"Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan A.","family":"Halm","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas"},{"name":"Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Alvarez","sequence":"additional","affiliation":[{"name":"Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas"},{"name":"Department of Pharmacy Practice, Texas Tech University Health Sciences Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"ioi210057r1","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"ioi210057r2","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.2337\/dc18-S009","article-title":"Cardiovascular disease and risk management: standards of medical care in diabetes-2018.","volume":"41","author":"American Diabetes Association","year":"2018","journal-title":"Diabetes Care"},{"issue":"1","key":"ioi210057r3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s00125-008-1179-5","article-title":"Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial.","volume":"52","author":"Holman","year":"2009","journal-title":"Diabetologia"},{"issue":"10","key":"ioi210057r4","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1093\/cid\/civ554","article-title":"Rosuvastatin worsens insulin resistance in HIV-infected adults on antiretroviral therapy.","volume":"61","author":"Erlandson","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"12","key":"ioi210057r5","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jacc.2009.10.053","article-title":"Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients.","volume":"55","author":"Koh","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"ioi210057r6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1758-5996-6-53","article-title":"Statins use is associated with poorer glycaemic control in a cohort of hypertensive patients with diabetes and without diabetes.","volume":"6","author":"Liew","year":"2014","journal-title":"Diabetol Metab Syndr"},{"issue":"3","key":"ioi210057r7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2310\/JIM.0b013e318197ec8b","article-title":"Effect of statins on fasting plasma glucose in diabetic and nondiabetic patients.","volume":"57","author":"Sukhija","year":"2009","journal-title":"J Investig Med"},{"issue":"5","key":"ioi210057r8","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00125-015-3528-5","article-title":"Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort.","volume":"58","author":"Cederberg","year":"2015","journal-title":"Diabetologia"},{"issue":"12","key":"ioi210057r9","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.jacc.2010.01.020","article-title":"Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial.","volume":"55","author":"Ridker","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"ioi210057r10","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2337\/dc06-1982","article-title":"Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: \u201cdouble diabetes\u201d in the Diabetes Control and Complications Trial.","volume":"30","author":"Kilpatrick","year":"2007","journal-title":"Diabetes Care"},{"issue":"6","key":"ioi210057r11","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism.","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"issue":"3","key":"ioi210057r12","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.jacl.2014.02.012","article-title":"An assessment by the Statin Diabetes Safety Task Force: 2014 update.","volume":"8","author":"Maki","year":"2014","journal-title":"J Clin Lipidol"},{"key":"ioi210057r14","doi-asserted-by":"publisher","first-page":"B10","DOI":"10.2337\/diacare.27.suppl_2.B10","article-title":"Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data.","volume":"27","author":"Miller","year":"2004","journal-title":"Diabetes Care"},{"issue":"1","key":"ioi210057r15","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.170","article-title":"Lactic acidosis incidence with metformin in patients with type 2 diabetes and chronic kidney disease: A retrospective nested case-control study.","volume":"4","author":"Alvarez","year":"2020","journal-title":"Endocrinol Diabetes Metab"},{"issue":"4","key":"ioi210057r16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","article-title":"The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application.","volume":"2","author":"Lund","year":"2015","journal-title":"Curr Epidemiol Rep"},{"issue":"7","key":"ioi210057r17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nrrheum.2015.30","article-title":"Active-comparator design and new-user design in observational studies.","volume":"11","author":"Yoshida","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"ioi210057r18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1177\/0962280211403603","article-title":"Observational data for comparative effectiveness research: an emulation of randomised trials of statins and primary prevention of coronary heart disease.","volume":"22","author":"Danaei","year":"2013","journal-title":"Stat Methods Med Res"},{"issue":"8","key":"ioi210057r19","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1056\/NEJMoa054017","article-title":"Body-mass index and mortality in Korean men and women.","volume":"355","author":"Jee","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"ioi210057r20","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/j.1550-8528.1999.tb00417.x","article-title":"Meta-analysis of the effect of excluding early deaths on the estimated relationship between body mass index and mortality.","volume":"7","author":"Allison","year":"1999","journal-title":"Obes Res"},{"issue":"4","key":"ioi210057r22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.4088\/JCP.v68n0407","article-title":"Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics.","volume":"68","author":"Henderson","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"ioi210057r23","doi-asserted-by":"publisher","first-page":"960","DOI":"10.2337\/diacare.15.8.960","article-title":"Trends in diabetes and diabetic complications, 1980-1987.","volume":"15","author":"Wetterhall","year":"1992","journal-title":"Diabetes Care"},{"issue":"2","key":"ioi210057r24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1367\/1539-4409(2001)001<0099:CAQOCF>2.0.CO;2","article-title":"Continuity and quality of care for children with diabetes who are covered by medicaid.","volume":"1","author":"Christakis","year":"2001","journal-title":"Ambul Pediatr"},{"issue":"8","key":"ioi210057r25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009952","article-title":"Systematic review of validated case definitions for diabetes in ICD-9-coded and ICD-10-coded data in adult populations.","volume":"6","author":"Khokhar","year":"2016","journal-title":"BMJ Open"},{"issue":"7","key":"ioi210057r26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.annepidem.2003.09.016","article-title":"Review of the performance of methods to identify diabetes cases among vital statistics, administrative, and survey data.","volume":"14","author":"Saydah","year":"2004","journal-title":"Ann Epidemiol"},{"issue":"6","key":"ioi210057r27","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"ioi210057r28","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study.","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"issue":"4","key":"ioi210057r29","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1111\/j.1475-6773.2007.00822.x","article-title":"Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database.","volume":"43","author":"Quan","year":"2008","journal-title":"Health Serv Res"},{"issue":"5","key":"ioi210057r30","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/ppe.2012.26.issue-5","article-title":"Validity of using ICD-9-CM codes to identify selected categories of obstetric complications, procedures and co-morbidities.","volume":"26","author":"Goff","year":"2012","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"10","key":"ioi210057r31","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1681\/ASN.2007020199","article-title":"Evaluation of the modification of diet in renal disease study equation in a large diverse population.","volume":"18","author":"Stevens","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"ioi210057r32","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1177\/1536867X0200200403","article-title":"Estimation of average treatment effects based on propensity scores.","volume":"2","author":"Becker","year":"2002","journal-title":"Stata J"},{"issue":"5","key":"ioi210057r34","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0895-4356(01)00510-8","article-title":"Calculating the \u201cnumber needed to be exposed\u201d with adjustment for confounding variables in epidemiological studies.","volume":"55","author":"Bender","year":"2002","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"ioi210057r35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s40256-016-0190-3","article-title":"Statins in primary prevention: uncertainties and gaps in randomized trial data.","volume":"16","author":"Mansi","year":"2016","journal-title":"Am J Cardiovasc Drugs"},{"issue":"19","key":"ioi210057r37","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1001\/jama.2019.3471","article-title":"Resurgence in diabetes-related complications.","volume":"321","author":"Gregg","year":"2019","journal-title":"JAMA"},{"issue":"7","key":"ioi210057r38","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes.","volume":"379","author":"Rawshani","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"ioi210057r39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11606-015-3556-3","article-title":"Diabetes and prior coronary heart disease are not necessarily risk equivalent for future coronary heart disease events.","volume":"31","author":"Rana","year":"2016","journal-title":"J Gen Intern Med"},{"issue":"14","key":"ioi210057r40","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1001\/archinte.161.14.1717","article-title":"The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up.","volume":"161","author":"Hu","year":"2001","journal-title":"Arch Intern Med"},{"issue":"5","key":"ioi210057r41","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1001\/archinternmed.2011.2","article-title":"Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors.","volume":"171","author":"Wannamethee","year":"2011","journal-title":"Arch Intern Med"},{"issue":"5","key":"ioi210057r42","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/archinternmed.2010.524","article-title":"Diabetes and cardiovascular risk equivalency: do age at diagnosis and disease duration affect risk stratification?: comment on \u201cimpact of diabetes on cardiovascular disease risk and all-cause mortality in older men\u201d.","volume":"171","author":"Idris","year":"2011","journal-title":"Arch Intern Med"},{"issue":"9435","key":"ioi210057r43","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"issue":"9965","key":"ioi210057r44","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0140-6736(14)61183-1","article-title":"HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.","volume":"385","author":"Swerdlow","year":"2015","journal-title":"Lancet"},{"issue":"11","key":"ioi210057r45","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.2337\/db13-1398","article-title":"Fluvastatin causes NLRP3 inflammasome-mediated adipose insulin resistance.","volume":"63","author":"Henriksbo","year":"2014","journal-title":"Diabetes"},{"issue":"11","key":"ioi210057r46","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.2337\/db14-1059","article-title":"Statin-induced insulin resistance through inflammasome activation: sailing between Scylla and Charybdis.","volume":"63","author":"Mitchell","year":"2014","journal-title":"Diabetes"},{"issue":"1","key":"ioi210057r47","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1152\/ajpendo.00329.2005","article-title":"Hexosamines, insulin resistance, and the complications of diabetes: current status.","volume":"290","author":"Buse","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"14","key":"ioi210057r48","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/NEJMoa1506930","article-title":"Pioglitazone after ischemic stroke or transient ischemic attack.","volume":"374","author":"Kernan","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"ioi210057r49","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1172\/JCI67166","article-title":"Insulin resistance in the vasculature.","volume":"123","author":"Mather","year":"2013","journal-title":"J Clin Invest"},{"issue":"7","key":"ioi210057r50","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1172\/JCI29024","article-title":"Insulin resistance and atherosclerosis.","volume":"116","author":"Semenkovich","year":"2006","journal-title":"J Clin Invest"},{"issue":"5","key":"ioi210057r51","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jdiacomp.2013.04.003","article-title":"Obesity and hyperlipidemia are risk factors for early diabetic neuropathy.","volume":"27","author":"Smith","year":"2013","journal-title":"J Diabetes Complications"},{"issue":"6","key":"ioi210057r52","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1001\/jamaneurol.2016.0256","article-title":"Understanding small fiber neuropathy: the long and short of it.","volume":"73","author":"Kissel","year":"2016","journal-title":"JAMA Neurol"},{"issue":"7","key":"ioi210057r53","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/SMJ.0b013e318259bad3","article-title":"Overtreatment and undertreatment of hyperlipidemia in the outpatient setting.","volume":"105","author":"Verma","year":"2012","journal-title":"South Med J"},{"issue":"1","key":"ioi210057r54","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1136\/jim-2016-000218","article-title":"Association of statins with diabetes mellitus and diabetic complications: role of confounders during follow-up.","volume":"65","author":"Mansi","year":"2017","journal-title":"J Investig Med"},{"issue":"4","key":"ioi210057r56","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1177\/1077558715617382","article-title":"Do Veterans Health Administration enrollees generalize to other populations?","volume":"73","author":"Wong","year":"2016","journal-title":"Med Care Res Rev"},{"key":"ioi210057r13","unstructured":"Health Services Research and Development. Accessed October 22, 2020. https:\/\/www.hsrd.research.va.gov\/for_researchers\/vinci\/cdw.cfm"},{"key":"ioi210057r21","unstructured":"Elixhauser? A, Steiner? C, Palmer? L. Clinical Classifications Software (CCS) for ICD-9-CM. Databases and related tools from the Healthcare Cost and Utilization Project (HCUP): appendix a. 2012. Accessed August 30, 2021. https:\/\/www.hcup-us.ahrq.gov\/toolssoftware\/ccs\/AppendixASingleDX.txt"},{"key":"ioi210057r33","unstructured":"Leuven? E, Sianesi? B. PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing, v 4.0.5. 2003. Accessed August 27, 2021. https:\/\/ideas.repec.org\/c\/boc\/bocode\/s432001.html?"},{"key":"ioi210057r36","unstructured":"US Centers for Disease Control and Prevention. US diabetes surveillance system and diabetes atlas. Assessed December 9, 2020. https:\/\/www.cdc.gov\/diabetes\/data?"},{"key":"ioi210057r55","unstructured":"Raebel? MA, Schroeder? E, Goodrich? G,  Validating type 1 and type 2 diabetes mellitus in the Mini-Sentinel Distributed Database using the Surveillance, Prevention, and Management of Diabetes Mellitus (SUPREME-DM) DataLink. Accessed on March 4, 2021. https:\/\/www.sentinelsystem.org\/sentinel\/methods\/validating-type-1-and-type-2-diabetes-mellitus-mini-sentinel-distributed-database?"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2784799\/jamainternal_mansi_2021_oi_210057_1638550210.45155.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T11:04:45Z","timestamp":1638788685000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2784799"}},"subtitle":["A Retrospective Matched-Cohort Study"],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2021.5714","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740921831.793589110","asserted-by":"object"}]},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,1]]}}}